NZ Inflammatory Bowel Disease Research Review Issue 24

In this issue:

Exercise reduces risk of CD
Efficacy of anti-TNF-α agents in UC
Thiopurine use and first intestinal resection in CD
Infliximab + azathioprine effective in UC
Oral + rectal mesalazine for mild-to-moderate UC
Small intestinal bacterial overgrowth
Anti-TNF use and malignancy risk in CD
The SONIC trial: CDAI, CRP and mucosal healing
Appendectomy and colitis: a mouse model
Mindfulness-based cognitive therapy for improving QoL in IBD
Science blog: Promising new therapeutic for IBD

Please login below to download this issue (PDF)

Subscribe